| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 03/13/2001 | US6200983 For treating erectile dysfunction in psychogenic male patients; time-release agents |
| 03/13/2001 | US6200548 Gas or air filled polymeric microballoons |
| 03/13/2001 | US6200547 Carrier including particles that include iron and carbon; therapeutic amount of doxorubicin or paclitaxel adsorbed on the particles. |
| 03/13/2001 | US6199385 Polarized gas accumulators and heating jackets and associated gas collection and thaw methods and polarized gas products |
| 03/08/2001 | WO2001016225A1 Radio-opaque molded plastic parts |
| 03/08/2001 | WO2001016176A2 Transgenic animal model for neurodegenerative diseases |
| 03/08/2001 | WO2001015744A1 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases |
| 03/08/2001 | WO2001015743A2 Viscosity-standardised compositions which facilitate swallowing in dysphagic subjects |
| 03/08/2001 | WO2001015742A1 Administering a gravity segregation dispersion by continuous infusion |
| 03/08/2001 | WO2001015628A2 In vivo screening methods for predicting calcification of implantable prosthetic material |
| 03/08/2001 | DE10039377A1 Thermochromic liquid crystal medium, useful for the production of inks for the security marking of documents, comprises a liquid crystalline mixture and a chiral doping agent. |
| 03/08/2001 | CA2383564A1 Transgenic animal model for neurodegenerative diseases |
| 03/08/2001 | CA2383095A1 Administering a gravity segregation dispersion by continuous infusion |
| 03/08/2001 | CA2382954A1 Radio-opaque molded plastic parts |
| 03/08/2001 | CA2381926A1 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases |
| 03/07/2001 | EP1081225A1 Transgenic animal model for neurodegenerative diseases |
| 03/07/2001 | EP1080199A2 (hemorrhagic enteritis) virus dna sequences, proteins encoded thereby and various uses thereof |
| 03/07/2001 | EP1079866A2 Methods of inhibiting clot formation |
| 03/07/2001 | EP1079865A1 Ultrasound contrast agent dispersions comprising gas and destabilising agent |
| 03/06/2001 | US6197956 Cyanine dyes and synthesis methods thereof |
| 03/06/2001 | US6197581 Human adenylate cyclase and use therefor |
| 03/06/2001 | US6197541 Nucleic acid which codes for mammalian receptor having seven transmembrane domains; drug screening of anticoagulants and wound healing agents; diagnosis of cardiovascular disorders; treatment of restenosis and unstable angina |
| 03/06/2001 | US6197333 Materials and methods for making improved liposome compositions |
| 03/06/2001 | US6197281 Wet appliable, instant protection sunscreen and makeup and method of use |
| 03/01/2001 | WO2001014875A1 CHEWING GUM FOR MEASURING ORAL pH, METHOD OF MAKING AND KIT |
| 03/01/2001 | WO2001013957A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 03/01/2001 | WO2001013946A2 Method for isolating and purifying grass pollen allergens |
| 03/01/2001 | WO2001013922A1 Drug for treating fractures |
| 03/01/2001 | WO2001013893A2 Use of simple amino acids to form porous particles |
| 03/01/2001 | WO2001013892A2 Large porous particles by spray-drying |
| 03/01/2001 | WO2000065060A3 Dna sequence and recombinant production of a graminae allergen |
| 03/01/2001 | WO2000032240B1 Radioconjugation of internalizing antibodies |
| 03/01/2001 | DE19940862A1 Röntgenkontrastierbare Kunststoffformteile Röntgenkontrastierbare plastic moldings |
| 03/01/2001 | DE19939982A1 Verfahren zur Isolierung und Aufreinigung von Gräserpollenallergenen A process for the isolation and purification of grass pollen allergens |
| 03/01/2001 | CA2383491A1 Large porous particles by spray-drying |
| 03/01/2001 | CA2381425A1 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 03/01/2001 | CA2381340A1 Method for isolating and purifying grass pollen allergens |
| 03/01/2001 | CA2381302A1 Drug for treating fractures |
| 02/28/2001 | EP1077998A1 Labelled glutamine and lysine analogues |
| 02/28/2001 | EP1077731A1 Intramolecularly-quenched near infrared fluorescent probes |
| 02/28/2001 | EP1077730A1 Contrast media |
| 02/28/2001 | EP1077729A2 Metal complexes derivatized with folate for use in diagnostic and therapeutic applications |
| 02/28/2001 | EP1077723A1 Methods and use of compositions comprising tnf-rii(p75) agonists for treating asthma and other allergic conditions |
| 02/28/2001 | CN1285818A Compound for antemortem diagnosis of alzheimer's disease and i(IN VIVO) imaging and prevention of amyloid deposition |
| 02/28/2001 | CN1285225A Stomach two-dimensinal ultrasonic ultrasonographic contrast powder and making technology thereof |
| 02/27/2001 | US6194386 Labelled peptide compounds |
| 02/27/2001 | US6194206 Use of oligonucleotide telomerase inhibitors to reduce telomere length |
| 02/27/2001 | US6193953 Stabilized microparticles and their use as ultrasound contrast agents |
| 02/27/2001 | US6193952 Longer lasting images of the heart and other internal organs |
| 02/27/2001 | US6193951 Microparticles useful as ultrasonic contrast agents |
| 02/27/2001 | US6193950 For diagnosis and therapy |
| 02/22/2001 | WO2001012674A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 02/22/2001 | WO2001012238A1 An animal model of polyglutamine toxicity, methods of use, and modulators of polyglutamine toxicity |
| 02/22/2001 | WO2001012237A1 Support materials and imaging method for intraoral diagnostic purposes |
| 02/22/2001 | WO2001012071A1 Microparticles useful as ultrasonic contrast agents and for lymphatic system |
| 02/22/2001 | WO2001012069A1 Hollow microspheres with controlled fragility for medical use |
| 02/22/2001 | WO2001011953A1 A large animal model of invasive pulmonary aspergillosis in an immunocompromised host |
| 02/22/2001 | WO2001011951A1 Mouse having human cytochrome p450 transferred therein |
| 02/22/2001 | CA2381706A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 02/22/2001 | CA2379311A1 A large animal model of invasive pulmonary aspergillosis in an immunocompromised host |
| 02/21/2001 | EP1077071A1 Labeled drugs and nitroxyl compounds to be used therein |
| 02/21/2001 | EP1076723A2 Use of cathepsin s in the diagnosis and treatment of endometriosis |
| 02/21/2001 | CN1285044A Method of magnetic resonance investigation |
| 02/21/2001 | CN1285040A Skin test for schizophrenia |
| 02/21/2001 | CN1284860A Microparticles and their therapeutic or diagnostic use |
| 02/20/2001 | US6191262 Contrast agent preparation |
| 02/20/2001 | US6191261 Immunoglobulin that preferential binds a growth factor; for the diagnosis and treatment of cell proliferative defects; antiproliferative agents |
| 02/20/2001 | US6191105 Insulin free compositions with insulin-methyl(ethylene glycol)-o-hexanoic acid conjugate and composition with water in oil microemulsion |
| 02/20/2001 | US6190877 Placing sample into culutre media, incubating with fluorescent marker while retaining viabilty, activating with light to cause fluorescence, and viewing; fluorescence indicates malignancy or pre-malignancy |
| 02/20/2001 | US6190661 Methods and compositions for the use of apurinic/apyrimidinic endonucleases |
| 02/20/2001 | US6190641 Indocyanine dyes |
| 02/15/2001 | WO2001010468A2 Drug-carrier complexes and methods of use thereof |
| 02/15/2001 | WO2000063296A3 Cyanine dyes and synthesis methods thereof |
| 02/15/2001 | WO2000045856A3 Novel methods of imaging and treatment with targeted compositions |
| 02/14/2001 | EP1075286A2 13c glucose breath test for the diagnosis of diabetes |
| 02/14/2001 | EP1075285A1 The use of a vital dye for facilitating surgical procedures for cataract extraction |
| 02/14/2001 | EP1075284A1 The use of a vital dye for facilitating surgical procedures for vitreo-retinal surgery |
| 02/14/2001 | EP1075280A2 Hemoglobine-haptoglobin complexes for targeted durg delivery |
| 02/14/2001 | EP1075277A2 Methods for detecting and inhibiting angiogenesis |
| 02/14/2001 | EP1075215A1 Hyaluronan-based imaging agents |
| 02/14/2001 | CN1284158A Polarized gas storage device and heating clamping sleeve and related gas collection, its molten method and polarized gas products |
| 02/14/2001 | CN1061893C Acoustical contrast agent |
| 02/13/2001 | US6187308 Ameliorating an immune response disorder. |
| 02/13/2001 | US6187288 Stable microbubble suspensions as enhancement agents for ultrasonic echography |
| 02/13/2001 | US6187287 Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells |
| 02/13/2001 | US6187285 Metal chelates of substituted polyaminocarboxylic macrocycles and their use in diagnostic imaging |
| 02/13/2001 | CA2059288C Fluorine and phosphorous-containing amphiphilic molecules with surfactant properties |
| 02/08/2001 | WO2001009188A1 Binding moieties for fibrin |
| 02/08/2001 | WO2001008712A2 Targeting multimeric imaging agents through multilocus binding |
| 02/08/2001 | WO2001008711A2 Stable microbubbles for the use as an ultrasound contrast agent |
| 02/08/2001 | WO2001008660A2 Targeted fiberless radiative effectors |
| 02/08/2001 | CA2384565A1 Targeting multimeric imaging agents through multilocus binding |
| 02/08/2001 | CA2376245A1 Binding moieties for fibrin |
| 02/07/2001 | EP1073716A2 Improvements in or relating to separation processes |
| 02/07/2001 | EP1073477A1 Methods for detecting lesions in dense breast tissue using lhrh antagonists |
| 02/07/2001 | EP1073476A1 Method and kit for obtaining fluids and cellular material from breast ducts |
| 02/07/2001 | EP1073475A2 Improvements in or relating to diagnostic/therapeutic agents |
| 02/07/2001 | EP1073474A1 Improvements in or relating to contrast agents |
| 02/07/2001 | EP1073473A1 Improvements in or relating to contrast agents |
| 02/07/2001 | EP1073472A1 Solution for diagnosing or treating tissue pathologies |